About Citrique Belge
Citrique Belge is a company based in Tienen (Belgium) founded in 1919 was acquired by Riflebird in June 2016. Citrique Belge offers products and services including Citric Acid, Citrates, Mycelium, Low K Vinasse, and Gypsum. Citrique Belge operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Tienen, Belgium
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Isabel Nv
-
Annual Revenue
Not available
-
Net Profit
-$19.87 K (USD)20as on Dec 31, 2022
-
EBITDA
-$11.08 K (USD)38as on Dec 31, 2022
-
Latest Funding Round
Not available
-
Investors
dsm-firmenich
& 2 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Citrique Belge
Citrique Belge offers a comprehensive portfolio of products and services, including Citric Acid, Citrates, Mycelium, Low K Vinasse, and Gypsum.
Produced through fermentation for food and industrial applications
Derived compounds used in various industrial processes
Fungal biomass for innovative and sustainable uses
Fermentation residue for agricultural or industrial applications
Co-product from processes for construction and soil uses
Extracted element for industrial and agricultural purposes
Salt form for food and health-related applications
Innovative fungal-based material for specific uses
Fungal product for barrier or protective applications
Funding Insights of Citrique Belge
Detailed funding history for Citrique Belge
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Citrique Belge
Citrique Belge has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include dsm-firmenich, ADCURAM and Riflebird.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health, nutrition, and bioscience solutions are delivered worldwide.
|
Locked | Locked | Locked | |
|
ADCURAM is focused on succession and carve-out investment solutions.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Citrique Belge
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Citrique Belge
Investment portfolio details for Citrique Belge
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Citrique Belge
Detailed financials for Citrique Belge
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Citrique Belge Comparisons
Peer comparison for Citrique Belge
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Citrique Belge
Citrique Belge operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Citrique Belge
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Citrique Belge
Complete news archive for Citrique Belge
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Citrique Belge
Citrique Belge was founded in 1919.
Citrique Belge is headquartered in Tienen, Belgium. It is registered at Tienen, Flemish Brabant, Belgium.
Citrique Belge was set up in 1916 to develop fermentation technology for producing citric acid. The company has since then developed deep expertise in the production of citric acid anhydrous and monohydrates, and citrate salts as ingredients in food and pharmaceuticals. Additionally, the company has developed methods to recover valuable animal feed ingredients from the spent media as well as the protein-rich mycelium.
Citrique Belge's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Citrique Belge offers Citric Acid, Citrates, Mycelium, Low K Vinasse, and 5 more products and services.
Citrique Belge has 3 investors. Key investors include dsm-firmenich, ADCURAM, and Riflebird.